Fundraising FoxConnecticut Innovations — 2017 Investments
8 investments dated 2017 · listed companies and verified rows first · show all
Atrius provides technology solutions for enterprise building management, including energy optimization, asset tracking, and wayfinding systems for physical spaces where people work, live, and gather.
CleantechClimate TechCloud ComputingEnergyEnterprise SoftwareIoTPropTechSaaS
Co-investorsTSVC
Inbox Health provides automated patient billing and communication tools for medical practices and billing companies, sending customized billing messages via email, text, paper mail, or voice calls with follow-ups that adapt to patient interactions.
Digital HealthFintechSaaSNew Haven, US
Lawrence Walker(Executive Officer, Director)David Sturek(Director)Alphonse Ippolito(Executive Officer)
BoardMatthew D. Storeygard(Director)inSteven Piaker(Director)Vivek Krishnamurthy(Director)in
Co-investorsAtento CapitalCollaborative FundCommerce VenturesHealthy VenturesLaunchCapitalVertical Venture Partners+1 more
ICN provides cloud-based, real-time promotion and coupon management technology for retailers, handling trade, digital, paper, mobile, and direct-to-card coupons and points at the point of sale.
AdTechRetail TechSaaSNew Canaan, US
Richard Thibedeau(Co-Founder & Chief Operating Officer)Jon Robertson(Co-Founder & EVP Marketing)inBrian Schulte(Co-Founder & VP of IT)inGary Oakley(Executive Officer, Director)
BoardJames Petras(Director)Jonathan Murray(Director)
Co-investorsEarly Stage Partners, LPLaunchCapital
IsoPlexis (now part of Bruker Cellular Analysis) provides single-cell functional profiling technology used to discover therapeutic antibodies, interrogate T cells for novel cell therapies, and accelerate cell line development.
BiotechDeep TechMedical DevicesNew Haven, US
Rong Fan(Director)Sean McKay(Executive Officer, Director)Sean Mackay(Executive Officer, Director)
BoardDaniel Wagner(Director)John Conley(Director)inGregory Ho(Director)
Co-investorsAlly Bridge GroupIronwood CapitalNorthpond VenturesSpring Mountain Capital
QCDx develops liquid biopsy technologies using live 3D imaging to detect and profile circulating tumor cells for cancer diagnosis and drug development.
BiotechMedical DevicesFarmington, US
Triantafyllos Tafas(Manager and Member of Issuer.)inTriantafyllos Tafas Ph.D.(Founder)in
BiotechNew Haven, US
Erika Smith(Executive Officer, Director)George Maynard(Executive Officer)
BoardDavid Wurzer(Director)Gregory Ho(Director)John Puziss(Director)
Co-investorsSpring Mountain Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.